Activated CAFs, in turn, induce podoplanin expression in carcinoma cells through the TGF-β–Smad pathway (Table 1 and Table 2) and enhance cell invasion by activating EGFR, AKT, and ERK signaling. The gene discussed is PDPN; the disease is carcinoma.